There may be scope for an agreement on drug exports to the US though in the other key area in dispute - regulation of digital services - room for compromise could be limited
The article discusses a potential deal to prevent Trump's 25% tariffs on Irish pharmaceuticals. During Taoiseach Micheál Martin's meeting with Trump, pharma is a central topic. The tariffs could breach WTO agreements and impact Ireland's economy, particularly corporate taxes. A possible deal might involve pharma companies increasing US profits and lowering consumer prices, while Ireland aims to retain most of its current arrangements. The EU may retaliate if no agreement is reached.
